News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

Synageva BioPharma (GEVA) To Present At The Nomura Biotechnology Conference



2/10/2014 10:10:09 AM

LEXINGTON, Mass., Oct. 29, 2014 /PRNewswire/ -- Synageva BioPharma Corp. (NASDAQ: GEVA), a biopharmaceutical company developing therapeutic products for rare disorders, announced today that Sanj K. Patel, President and Chief Executive Officer of Synageva, will present at the Nomura Biotechnology Conference in Boston, MA on Thursday, November 6, 2014, at 8:00 a.m. EST.  The presentation will be webcast live and may be accessed from the "Webcasts & Presentations" section of the Investor Relations tab on the home page of Synageva's website at www.synageva.com.

Synageva routinely posts information that may be important to investors in the "Investor Relations" section of the company's website at www.synageva.com. Synageva encourages investors and potential investors to consult this website regularly for important information about the company.

Further information regarding Synageva BioPharma Corp. is available at www.synageva.com.

"Synageva BioPharma" is a trademark, and "Dedicated to Rare Diseases" is a registered trademark, of Synageva. 

SOURCE Synageva BioPharma Corp.

Help employers find you! Check out all the jobs and post your resume.

Read at BioSpace.com


comments powered by Disqus
   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES